373 related articles for article (PubMed ID: 27461230)
1. From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis.
Choi YM; Debbaneh M; Weinberg JM; Yamauchi PS; Van Voorhees AS; Armstrong AW; Siegel M; Wu JJ
J Am Acad Dermatol; 2016 Oct; 75(4):798-805.e7. PubMed ID: 27461230
[TBL] [Abstract][Full Text] [Related]
2. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
[TBL] [Abstract][Full Text] [Related]
3. To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis.
Ahn CS; Dothard EH; Garner ML; Feldman SR; Huang WW
J Am Acad Dermatol; 2015 Sep; 73(3):420-8.e1. PubMed ID: 26184440
[TBL] [Abstract][Full Text] [Related]
4. Perioperative management of medications for psoriasis and psoriatic arthritis: a review for the dermasurgeon.
Hernandez C; Emer J; Robinson JK
Dermatol Surg; 2008 Apr; 34(4):446-59. PubMed ID: 18248470
[TBL] [Abstract][Full Text] [Related]
5. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.
Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation
J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527
[TBL] [Abstract][Full Text] [Related]
6. Infliximab in psoriasis and psoriatic arthritis.
Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
[TBL] [Abstract][Full Text] [Related]
7. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
Mease PJ; Goffe BS; Metz J; VanderStoep A; Finck B; Burge DJ
Lancet; 2000 Jul; 356(9227):385-90. PubMed ID: 10972371
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
[TBL] [Abstract][Full Text] [Related]
9. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.
Hugh J; Van Voorhees AS; Nijhawan RI; Bagel J; Lebwohl M; Blauvelt A; Hsu S; Weinberg JM
J Am Acad Dermatol; 2014 Jan; 70(1):168-77. PubMed ID: 24184141
[TBL] [Abstract][Full Text] [Related]
10. [Biological treatment of psoriasis and psoriatic arthritis].
Kragballe K; Deleuran B
Ugeskr Laeger; 2008 Jun; 170(24):2148-50. PubMed ID: 18565300
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
12. Treatment of psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis.
Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J
JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis.
Mori Y; Kuwahara Y; Chiba S; Itoi E
Mod Rheumatol; 2015 May; 25(3):431-4. PubMed ID: 25295919
[TBL] [Abstract][Full Text] [Related]
15. The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures.
Bakkour W; Purssell H; Chinoy H; Griffiths CE; Warren RB
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):86-91. PubMed ID: 25732669
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based review of the mechanism of action, efficacy, and safety of biologic therapies in the treatment of psoriasis and psoriatic arthritis.
Brezinski EA; Armstrong AW
Curr Med Chem; 2015; 22(16):1930-42. PubMed ID: 25921645
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review.
Boehncke WH; Alvarez Martinez D; Solomon JA; Gottlieb AB
J Rheumatol; 2014 Nov; 41(11):2301-5. PubMed ID: 25362715
[TBL] [Abstract][Full Text] [Related]
18. Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis.
Henderson Berg MH; Carrasco D
J Drugs Dermatol; 2017 Jul; 16(7):695-698. PubMed ID: 28697222
[TBL] [Abstract][Full Text] [Related]
19. Psoriatic arthritis: current therapy and future approaches.
Huynh D; Kavanaugh A
Rheumatology (Oxford); 2015 Jan; 54(1):20-8. PubMed ID: 25125588
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
